Safety and Toxicity Issues of Therapeutically Used Nanoparticles from the Oral Route
暂无分享,去创建一个
[1] Lanze Liu,et al. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics , 2021, Journal of Nanobiotechnology.
[2] P. Opanasopit,et al. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery , 2021, Pharmaceutical development and technology.
[3] Stephen Kennedy,et al. Carbon Nanotube–Liposome Complexes in Hydrogels for Controlled Drug Delivery via Near-Infrared Laser Stimulation , 2020, ACS Applied Nano Materials.
[4] Zhuge Xi,et al. Toxic effects of the food additives titanium dioxide and silica on the murine intestinal tract: Mechanisms related to intestinal barrier dysfunction involved by gut microbiota. , 2020, Environmental toxicology and pharmacology.
[5] P. Leng,et al. Oral drug delivery with nanoparticles into the gastrointestinal mucosa , 2020, Fundamental & clinical pharmacology.
[6] Yuanyuan Wang,et al. The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs , 2020, International journal of nanomedicine.
[7] E. Muñoz,et al. Toxicity of Carbon Nanomaterials and Their Potential Application as Drug Delivery Systems: In Vitro Studies in Caco-2 and MCF-7 Cell Lines , 2020, Nanomaterials.
[8] A. Mohammad,et al. The Potential of Silver Nanoparticles for Antiviral and Antibacterial Applications: A Mechanism of Action , 2020, Nanomaterials.
[9] Å. Keita,et al. The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability , 2020, Cells.
[10] Junbo Xie,et al. Mechanism of the Intestinal Absorption of Six Flavonoids from Zizyphi Spinosi Semen Across Caco-2 Cell Monolayer Model. , 2020, Current drug metabolism.
[11] K. C. Sekhar,et al. Green Synthesized Ag Nanoparticles for Bio-Sensing and Photocatalytic Applications , 2020, ACS omega.
[12] S. Hua. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors , 2020, Frontiers in Pharmacology.
[13] Maryam Rameshrad,et al. Monitoring of drug resistance towards reducing the toxicity of pharmaceutical compounds: Past, present and future. , 2020, Journal of pharmaceutical and biomedical analysis.
[14] Y. Pellequer,et al. Small silica nanoparticles transiently modulate the intestinal permeability by actin cytoskeleton disruption in both Caco-2 and Caco-2/HT29-MTX models , 2020, Archives of Toxicology.
[15] Mi-Kyung Lee. Liposomes for Enhanced Bioavailability of Water-Insoluble Drugs: In Vivo Evidence and Recent Approaches , 2020, Pharmaceutics.
[16] V. K. Venuganti,et al. Effect of particle size and surface charge of nanoparticles in penetration through intestinal mucus barrier , 2020, Journal of Nanoparticle Research.
[17] Shik Nie Kong,et al. Oral administration of protein nanoparticles: An emerging route to disease treatment. , 2020, Pharmacological research.
[18] Hongbo Zhang,et al. Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery. , 2020, ACS applied bio materials.
[19] D. Drucker. Advances in oral peptide therapeutics , 2019, Nature Reviews Drug Discovery.
[20] K. Adibkia,et al. Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine , 2019, Advanced pharmaceutical bulletin.
[21] F. Lotfipour,et al. A brief overview on nano-sized materials used in the topical treatment of skin and soft tissue bacterial infections , 2019, Expert opinion on drug delivery.
[22] H. M. Nielsen,et al. The distribution of cell-penetrating peptides on polymeric nanoparticles prepared using microfluidics and elucidated with small angle X-ray scattering. , 2019, Journal of colloid and interface science.
[23] Simin Sharifi,et al. The Application of Nanomaterials in Cardiovascular Diseases: A Review on Drugs and Devices , 2019, Journal of Pharmacy & Pharmaceutical Sciences.
[24] T. Orsière,et al. Toxicological Assessment of ITER-Like Tungsten Nanoparticles Using an In Vitro 3D Human Airway Epithelium Model , 2019, Nanomaterials.
[25] Jun‐Seok Oh,et al. How membrane lipids influence plasma delivery of reactive oxygen species into cells and subsequent DNA damage: an experimental and computational study. , 2019, Physical chemistry chemical physics : PCCP.
[26] J. Lazniewska,et al. Cytotoxicity of Dendrimers , 2019, Biomolecules.
[27] Mohammad Hasanzadeh,et al. Current analytical approaches in diagnosis of melanoma , 2019, TrAC Trends in Analytical Chemistry.
[28] M. Tyska,et al. PACSIN2-dependent apical endocytosis regulates the morphology of epithelial microvilli , 2019, bioRxiv.
[29] Clive G. Wilson,et al. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[30] C. Drummond,et al. Encapsulation in egg white protein nanoparticles protects anti-oxidant activity of curcumin. , 2019, Food chemistry.
[31] Haitao Huang,et al. Multi-walled carbon nanotube-based systems for improving the controlled release of insoluble drug dipyridamole , 2019, Experimental and therapeutic medicine.
[32] Oral delivery of proteins and peptides by mucoadhesive nanoparticles , 2019, Biointerface Research in Applied Chemistry.
[33] H. Valizadeh,et al. Evaluation of anti-inflammatory impact of dexamethasone-loaded PCL-PEG-PCL micelles on endotoxin-induced uveitis in rabbits , 2019, Pharmaceutical development and technology.
[34] F. Lotfipour,et al. Freeze-thaw-induced cross-linked PVA/chitosan for oxytetracycline-loaded wound dressing: the experimental design and optimization , 2019, Research in pharmaceutical sciences.
[35] W. Parak,et al. Investigating Possible Enzymatic Degradation on Polymer Shells around Inorganic Nanoparticles , 2019, International journal of molecular sciences.
[36] M. Neek,et al. Protein-based nanoparticles in cancer vaccine development. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[37] K. Adibkia,et al. An Alternative Approach for Improved Entrapment Efficiency of Hydrophilic Drug Substance in PLGA Nanoparticles by Interfacial Polymer Deposition Following Solvent Displacement , 2018, Jundishapur Journal of Natural Pharmaceutical Products.
[38] F. Cassee,et al. Toxicity of copper oxide and basic copper carbonate nanoparticles after short-term oral exposure in rats , 2018, Nanotoxicology.
[39] M. Tyska,et al. IRTKS (BAIAP2L1) Elongates Epithelial Microvilli Using EPS8-Dependent and Independent Mechanisms , 2018, Current Biology.
[40] S. Salatin,et al. Box–Behnken experimental design for preparation and optimization of the intranasal gels of selegiline hydrochloride , 2018, Drug development and industrial pharmacy.
[41] Huajian Gao,et al. Rapid transport of deformation-tuned nanoparticles across biological hydrogels and cellular barriers , 2018, Nature Communications.
[42] S. Salatin,et al. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery , 2018, Cancer Chemotherapy and Pharmacology.
[43] D. Vllasaliu,et al. Intestinal uptake and transport of albumin nanoparticles: potential for oral delivery. , 2018, Nanomedicine.
[44] G. Zhu,et al. Electrochemical sensing of 4-nitrochlorobenzene based on carbon nanohorns/graphene oxide nanohybrids. , 2018, Biosensors & bioelectronics.
[45] David J Brayden,et al. Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae. , 2018, International journal of pharmaceutics.
[46] P. Ganesan,et al. Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery , 2017 .
[47] M. Campagna,et al. The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group , 2017, Particle and Fibre Toxicology.
[48] Xincai Xiao,et al. Natural material-decorated mesoporous silica nanoparticle container for multifunctional membrane-controlled targeted drug delivery , 2017, International journal of nanomedicine.
[49] R. Chuck,et al. Safety of Nonporous Silica Nanoparticles in Human Corneal Endothelial Cells , 2017, Scientific Reports.
[50] Hari Sowrirajan,et al. Impact of Silver and Iron Nanoparticle Exposure on Cholesterol Uptake by Macrophages , 2017, Journal of nanomaterials.
[51] F. Reimann,et al. Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity , 2017, Mucosal Immunology.
[52] C. Cho,et al. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[53] H. Bouwmeester,et al. Effects of food‐borne nanomaterials on gastrointestinal tissues and microbiota , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[54] Laura M Ensign,et al. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[55] N. N. Belyaeva,et al. Structural and Functional Analysis of the Small Intestine in Rats After Six-Month-Long Exposure to Multiwalled Carbon Nanotubes , 2016, Bulletin of Experimental Biology and Medicine.
[56] Mahdieh Rahmani,et al. Fast Dissolving Sublingual Films Containing Sumatriptan Alone and Combined with Methoclopramide: Evaluation in Vitro Drug Release and Mucosal Permeation , 2016 .
[57] M. Pumera,et al. Air-stable superparamagnetic metal nanoparticles entrapped in graphene oxide matrix , 2016, Nature Communications.
[58] Siqi Zhu,et al. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec) , 2016, Drug delivery.
[59] D. Jain,et al. Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs , 2016, Scientifica.
[60] L. Hoffmann,et al. Effects of silver nanoparticles and ions on a co-culture model for the gastrointestinal epithelium , 2015, Particle and Fibre Toxicology.
[61] D. Mcclements,et al. Uptake of Gold Nanoparticles by Intestinal Epithelial Cells: Impact of Particle Size on Their Absorption, Accumulation, and Toxicity. , 2015, Journal of agricultural and food chemistry.
[62] Xiaoxiao Cai,et al. Independent effect of polymeric nanoparticle zeta potential/surface charge, on their cytotoxicity and affinity to cells , 2015, Cell proliferation.
[63] B. Conway,et al. Modification of drug delivery to improve antibiotic targeting to the stomach. , 2015, Therapeutic delivery.
[64] Z. Teng,et al. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. , 2015, Carbohydrate polymers.
[65] P. P. Kundu,et al. Assessment of in vivo chronic toxicity of chitosan and its derivates used as oral insulin carriers , 2015 .
[66] B. Manshian,et al. (Intra)cellular stability of inorganic nanoparticles: effects on cytotoxicity, particle functionality, and biomedical applications. , 2015, Chemical reviews.
[67] Steffen Loft,et al. In vivo toxicity of cationic micelles and liposomes. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[68] J. Dolatabadi,et al. Nano graphene oxide: a novel carrier for oral delivery of flavonoids. , 2014, Colloids and surfaces. B, Biointerfaces.
[69] Bruno Sarmento,et al. The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium. , 2014, Biomaterials.
[70] Yan Zhang,et al. Decanoic acid grafted oligochitosan nanoparticles as a carrier for insulin transport in the gastrointestinal tract. , 2014, Carbohydrate polymers.
[71] Jarno Salonen,et al. Fabrication of a Multifunctional Nano‐in‐micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix , 2014, Advanced materials.
[72] Meiying Wang,et al. Aspect ratio plays a role in the hazard potential of CeO2 nanoparticles in mouse lung and zebrafish gastrointestinal tract. , 2014, ACS nano.
[73] H. Bouwmeester,et al. Sub-chronic toxicity study in rats orally exposed to nanostructured silica , 2014, Particle and Fibre Toxicology.
[74] Hyun-Jong Cho,et al. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake , 2014, International journal of nanomedicine.
[75] A. K. Kondapi,et al. A Target-Specific Oral Formulation of Doxorubicin-Protein Nanoparticles: Efficacy and Safety in Hepatocellular Cancer , 2013, Journal of Cancer.
[76] Vesa-Pekka Lehto,et al. Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[77] V. Demin,et al. Transfer of Silver Nanoparticles through the Placenta and Breast Milk during in vivo Experiments on Rats , 2013, Acta naturae.
[78] Frank A Witzmann,et al. Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. , 2013, International journal of biomedical nanoscience and nanotechnology.
[79] H. Ghandehari,et al. Charge affects the oral toxicity of poly(amidoamine) dendrimers. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[80] U. Murty,et al. Biochemical alterations induced by acute oral doses of iron oxide nanoparticles in Wistar rats , 2013, Drug and chemical toxicology.
[81] Kai Yang,et al. In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. , 2013, Biomaterials.
[82] A. Youssef. Polymer Nanocomposites as a New Trend for Packaging Applications , 2013 .
[83] Linlin Li,et al. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. , 2013, Biomaterials.
[84] F. Wang,et al. Application of Drug Nanocrystal Technologies on Oral Drug Delivery of Poorly Soluble Drugs , 2013, Pharmaceutical Research.
[85] M. Rekha,et al. Oral delivery of therapeutic protein/peptide for diabetes--future perspectives. , 2013, International journal of pharmaceutics.
[86] Jianqing Gao,et al. Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies , 2012, International journal of nanomedicine.
[87] J. Hanes,et al. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. , 2012, Advanced drug delivery reviews.
[88] Mandy B. Esch,et al. Oral exposure to polystyrene nanoparticles affects iron absorption. , 2012, Nature nanotechnology.
[89] Zhenhai Zhang,et al. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine. , 2012, Die Pharmazie.
[90] U. Vogel,et al. Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats , 2012, Archives of Toxicology.
[91] Zigang Xu,et al. Changes in Small Intestinal Morphology and Digestive Enzyme Activity with Oral Administration of Copper-Loaded Chitosan Nanoparticles in Rats , 2012, Biological Trace Element Research.
[92] Mei-Chin Chen,et al. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. , 2011, Biomaterials.
[93] E. Souto,et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. , 2011, Colloids and surfaces. B, Biointerfaces.
[94] V. Préat,et al. Fate of polymeric nanocarriers for oral drug delivery , 2011 .
[95] Hans Bouwmeester,et al. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. , 2011, ACS nano.
[96] H. Swai,et al. In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles. , 2010, Toxicology and applied pharmacology.
[97] C. Lehr,et al. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. , 2010, Molecular pharmaceutics.
[98] A. Oomen,et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. , 2010, Biomaterials.
[99] I. Yu,et al. Subchronic oral toxicity of silver nanoparticles , 2010, Particle and Fibre Toxicology.
[100] Vesa-Pekka Lehto,et al. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. , 2010, ACS nano.
[101] M. Thanou,et al. Biodegradation, biodistribution and toxicity of chitosan. , 2010, Advanced drug delivery reviews.
[102] Lichen Yin,et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. , 2009, Biomaterials.
[103] I. M. Shaikh,et al. Lipid-based nanoparticulate systems for the delivery of anti-cancer drug cocktails: Implications on pharmacokinetics and drug toxicities. , 2009, Current drug metabolism.
[104] C. Lehr,et al. PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat , 2009, Pharmaceutical Research.
[105] B. Prasad,et al. Acute and subacute toxicity studies of chitosan reduced gold nanoparticles: a novel carrier for therapeutic agents. , 2009, Journal of biomedical nanotechnology.
[106] M. Fondevila,et al. Silver nanoparticles as a potential antimicrobial additive for weaned pigs. , 2009 .
[107] M. Yudasaka,et al. Toxicity of single-walled carbon nanohorns. , 2008, ACS nano.
[108] F. Veiga,et al. Toxicological assessment of orally delivered nanoparticulate insulin , 2008 .
[109] A. Basit,et al. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in‐vivo experiments , 2008, The Journal of pharmacy and pharmacology.
[110] I. Yu,et al. Twenty-Eight-Day Oral Toxicity, Genotoxicity, and Gender-Related Tissue Distribution of Silver Nanoparticles in Sprague-Dawley Rats , 2008 .
[111] Yan Li,et al. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. , 2007, Life sciences.
[112] Shubiao Zhang,et al. Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[113] J. Gao,et al. Safety evaluation of short-term exposure to chitooligomers from enzymic preparation. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[114] J. Nah,et al. Influence of molecular weight on oral absorption of water soluble chitosans. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[115] M. Hirose,et al. Subchronic toxicity study of dietary N-acetylglucosamine in F344 rats. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[116] R M Albrecht,et al. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.
[117] Claus-Michael Lehr,et al. Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa , 2001, Pharmaceutical Research.
[118] T. Kararli. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.
[119] J. Hardcastle,et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. , 1988, Gut.
[120] Kannan M. Krishnan,et al. In vivo Delivery, Pharmacokinetics, Biodistribution and Toxicity of Iron Oxide Nanoparticles , 2016 .
[121] Keyvan Nasirzadeh,et al. In vivo toxicity of orally administrated silicon dioxide nanoparticles in healthy adult mice , 2014, Environmental Science and Pollution Research.
[122] U. Murty,et al. Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment. , 2013, Toxicology and applied pharmacology.
[123] S. Iyuke,et al. A Review of Nanoparticles Toxicity and Their Routes of Exposures , 2012 .
[124] Amit Jain,et al. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. , 2011, Biomaterials.
[125] I. Yu,et al. Histochemical study of intestinal mucins after administration of silver nanoparticles in Sprague–Dawley rats , 2009, Archives of Toxicology.
[126] G. Abraham,et al. Management of Rheumatoid Arthritis: Rationale for the Use of Colloidal Metallic Gold , 1997 .
[127] Peixun Liu,et al. International Journal of Nanomedicine Dovepress Toxicologic Effects of Gold Nanoparticles in Vivo by Different Administration Routes , 2022 .